Cell-Free DNA Could Detect Adverse Events from Immunotherapy
December 10, 2025
December 10, 2025
BALTIMORE, Maryland, Dec. 10 -- Johns Hopkins Medicine posted the following news release:
* * *
Cell-Free DNA Could Detect Adverse Events from Immunotherapy
*
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns Hopkins Kimmel Cancer Center have found.
In a Dec. 11 letter to the editor o . . .
* * *
Cell-Free DNA Could Detect Adverse Events from Immunotherapy
*
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns Hopkins Kimmel Cancer Center have found.
In a Dec. 11 letter to the editor o . . .